Clinical features and prognostic factors in spinal meningioma surgery from a multicenter study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 06 2021
Historique:
received: 29 10 2020
accepted: 24 05 2021
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 6 11 2021
Statut: epublish

Résumé

Meningiomas are benign tumors that are treated surgically. Local recurrence is likely if the dura is preserved, and en bloc tumor and dura resection (Simpson grade I) is recommended. In some cases the dura is cauterized and preserved after tumor resection (Simpson grade II). The purpose of this study was performed to analyze clinical features and prognostic factors associated with spinal meningioma, and to identify the most effective surgical treatment. The subjects were 116 patients (22 males, 94 females) with spinal meningioma who underwent surgery at seven NSG centers between 1998 and 2018. Clinical data were collected from the NSG database. Pre- and postoperative neurological status was defined using the modified McCormick scale. The patients had a mean age of 61.2 ± 14.8 years (range 19-91 years) and mean symptom duration of 11.3 ± 14.7 months (range 1-93 months). Complete resection was achieved in 108 cases (94%), including 29 Simpson grade I and 79 Simpson grade II resections. The mean follow-up period was 84.8 ± 52.7 months. At the last follow-up, neurological function had improved in 73 patients (63%), was stable in 34 (29%), and had worsened in 9 (8%). Eight patients had recurrence, and recurrence rates did not differ significantly between Simpson grades I and II in initial surgery. Kaplan-Meier analysis of recurrence-free survival showed that Simpson grade III or IV, male, and dural tail sign were significant factors associated with recurrence (P < 0.05). In conclusion, Simpson I resection is anatomically favorable for spinal meningiomas. Younger male patients with a dural tail and a high-grade tumor require close follow-up. The tumor location and feasibility of surgery can affect the surgical morbidity in Simpson I or II resection. All patients should be carefully monitored for long-term outcomes, and we recommend lifelong surveillance after surgery.

Identifiants

pubmed: 34079036
doi: 10.1038/s41598-021-91225-z
pii: 10.1038/s41598-021-91225-z
pmc: PMC8172892
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

11630

Références

Surg Neurol. 1996 Nov;46(5):458-63; discussion 463-4
pubmed: 8874546
Am J Epidemiol. 2006 Oct 1;164(7):629-36
pubmed: 16835295
Acta Neurol Scand. 1988 Jan;77(1):27-30
pubmed: 3354308
J Korean Neurosurg Soc. 2007 Oct;42(4):300-4
pubmed: 19096560
J Korean Neurosurg Soc. 2013 Nov;54(5):373-8
pubmed: 24379942
Neurosurg Focus. 2003 Jun 15;14(6):e2
pubmed: 15669787
Acta Neurochir (Wien). 2008 Jun;150(6):551-6; discussion 556
pubmed: 18421413
J Neurosurg Spine. 2015 Sep;23(3):368-73
pubmed: 26023898
Radiology. 1990 Aug;176(2):447-50
pubmed: 2367659
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
Spine (Phila Pa 1976). 2012 Oct 15;37(22):E1398-401
pubmed: 22805341
Surg Neurol Int. 2018 Jan 25;9:16
pubmed: 29497569
Neurochirurgie. 2013 Feb;59(1):30-4
pubmed: 23395186
World Neurosurg. 2015 Apr;83(4):627-34
pubmed: 25527885
Eur Spine J. 2008 Aug;17(8):1035-41
pubmed: 18481118
J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39
pubmed: 13406590
J Neurosurg. 1989 Dec;71(6):842-5
pubmed: 2585075
Neurosurgery. 1989 Aug;25(2):153-60
pubmed: 2671779
J Neurosurg. 1990 Apr;72(4):523-32
pubmed: 2319309
Spine (Phila Pa 1976). 2015 Aug 1;40(15):E886-9
pubmed: 25996535
Spine (Phila Pa 1976). 2012 May 1;37(10):E617-23
pubmed: 22146282
J Orthop Sci. 2018 Mar;23(2):266-272
pubmed: 29191390
Neurosurg Focus. 2007;23(4):E14
pubmed: 17961038
Spine (Phila Pa 1976). 2000 Mar 15;25(6):727-31
pubmed: 10752106
Eur J Radiol. 2006 Dec;60(3):387-91
pubmed: 16876365
J Neurosurg. 2003 Apr;98(3 Suppl):258-63
pubmed: 12691381
J Neurosurg Sci. 2002 Mar;46(1):18-24
pubmed: 12118219
Pathol Res Pract. 2000;196(7):483-8
pubmed: 10926326
Neurosurg Focus. 2016 Aug;41(2):E6
pubmed: 27476848
Acta Neurochir (Wien). 2020 Jun;162(6):1401-1408
pubmed: 32166387
J Neurosurg. 1982 Dec;57(6):804-12
pubmed: 7143063
Clin Neurol Neurosurg. 2014 Mar;118:65-8
pubmed: 24529232
J Neurooncol. 2004 Mar-Apr;67(1-2):209-14
pubmed: 15072469
Spine (Phila Pa 1976). 2001 Aug 15;26(16):1805-8
pubmed: 11493855
J Neurooncol. 2018 Dec;140(3):639-647
pubmed: 30209689
Neurosurgery. 2017 Apr 1;80(4):602-609
pubmed: 28362922
J Neurooncol. 2010 Sep;99(3):307-14
pubmed: 20821343
Spine (Phila Pa 1976). 2011 Apr 15;36(8):E531-7
pubmed: 21178841
Surg Neurol. 1999 Dec;52(6):552-62
pubmed: 10660020
Surg Neurol Int. 2014 Aug 28;5(Suppl 7):S333-8
pubmed: 25289155
Cancer. 2000 Sep 1;89(5):1102-10
pubmed: 10964341
Clin Neurol Neurosurg. 2011 Jan;113(1):34-8
pubmed: 20926180
Turk Neurosurg. 2011;21(4):449-53
pubmed: 22194098
Neurosurg Focus. 2004 Jul 15;17(1):ECP2
pubmed: 15264778
Br J Neurosurg. 1998 Dec;12(6):521-6
pubmed: 10070460
J Neurosurg Sci. 2005 Mar;49(1):7-11
pubmed: 15990713
Cancer. 2012 Sep 1;118(17):4220-7
pubmed: 22907705

Auteurs

Kazuyoshi Kobayashi (K)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan. k_koba1@f2.dion.ne.jp.

Kei Ando (K)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Tomohiro Matsumoto (T)

Department of Orthopaedic Surgery, Chubu Rosai Hospital, 1-10-6, Komei-cho, Minami-ku, Nagoya, Aichi, 455-8530, Japan.

Koji Sato (K)

Department of Orthopaedic Surgery, Japanese Red Cross Nagoya Daini Hospital, Myokencho 2-9, Syowa-ku, Nagoya, Aichi, 466-8650, Japan.

Fumihiko Kato (F)

Department of Orthopaedic Surgery, Chubu Rosai Hospital, 1-10-6, Komei-cho, Minami-ku, Nagoya, Aichi, 455-8530, Japan.

Tokumi Kanemura (T)

Department of Orthopaedic Surgery, Konan Kousei Hospital, 137, Takaya-cho, Omatsubara, Takaya-cho, Konan, Aichi, 483-8704, Japan.

Hisatake Yoshihara (H)

Department of Orthopaedic Surgery, Toyohashi Municipal Hospital, 50 Aza Hachiken Nishi, Aotake-cho, Toyohashi, Aichi, 441-8570, Japan.

Yoshihito Sakai (Y)

Department of Orthopaedic Surgery, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan.

Atsuhiko Hirasawa (A)

Department of Orthopaedic Surgery, Aichi Medical University Hospital, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Hiroaki Nakashima (H)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Shiro Imagama (S)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH